Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

St James University Hospital
Leeds
LS9 7TF


Skip to Main Content

Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis

Stopped

Open to: All Genders

Age: 6 Years - N/A

Medical Conditions

Cystic Fibrosis


Study summary

This is an open-label extension study for participants who completed a Phase 3, placebo-controlled study of ataluren in participants with nonsense mutation cystic fibrosis (nmCF) not receiving chronic inhaled aminoglycosides.

The primary objective of this Phase 3 extension study will be to obtain long-term safety data to augment the overall safety database. The secondary objectives will be to augment the efficacy data collected in the double-blind study (PTC124-GD-021-CF; NCT02139306).


Key dates

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Aug 2015

Jun 2017

Study type

Interventional

Intervention Type : Drug
Intervention Name : Ataluren
Intervention Description : Ataluren will be provided as a vanilla-flavored powder to be mixed with water or milk.

Intervention Arm Group : Ataluren

Who can take part?

You can take part if:


Inclusion Criteria:

- Completion of study treatment (placebo or active) in the previous Phase 3, double-blind study protocol (Protocol PTC124-GD-021-CF)

- Evidence of signed and dated informed consent/assent document(s) indicating that the participant (and/or the participant's parent/legal guardian) has been informed of all pertinent aspects of the trial.

Exclusion Criteria:

- Known hypersensitivity to any of the ingredients or excipients of the study drug.

- Ongoing participation in any other therapeutic clinical trial.




You may not be able to take part if:

This is in the inclusion criteria above


Where can I take part?

Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • St James University Hospital
    Leeds
    LS9 7TF
  • Royal Brompton Hospital
    London
    SW3 6NP

Funders/Sponsors


The study is sponsored by PTC Therapeutics .



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details

for Trial ID: NCT02456103

Last updated

This page is to help you find out about a research study and if you may be able to take part

The information is provided by researchers and we rely on them to keep it up-to-date. You can see more information by clicking on the 'Read full details' link above.

To take part, please print or share the study information with your GP/healthcare provider or contact the research team directly.